1)Irinotecan(CPT-11)伊立替康(CPT-11)
2)Irinotecan伊立替康
1.Advancement in the Synthesis and Clinical Application of the New Anticancer Drug Irinotecan;抗肿瘤新药伊立替康的合成和应用进展
2.The adverse reactions and management of irinotecan;盐酸伊立替康的不良反应及其预防处理
3.Short-term effects of irinotecan plus capecitabine as first-line treatment for advanced colorectal carcinoma;伊立替康联合卡培他滨—线治疗晚期结直肠癌的近期疗效
英文短句/例句
1.Irinotecan in the Treament of Small Cell Lung Cancer (SCLC): A Systematic Review伊立替康治疗小细胞肺癌的系统评价
2.Effect of Irinotecan Combined with Radiotherapy in Patients with Advanced Non-small Cell Lung Cancer伊立替康联合放疗治疗晚期NSCLC的疗效
3.Clinical comparison between single agent of irinotecan and combination of irinotecan and cispaltin in second-line treatment of small cell lung cancer伊立替康单药与伊立替康联合顺铂二线治疗小细胞肺癌的临床比较
4.Preparation of Irinotecan Hydrochloride Liposome and the in Vitro and in Vivo Pharmaceutical Behaviors of Irinotecan Liposome;伊立替康脂质体的制备及体内外行为研究
5.Determination of Stabilization of Irinotecan in 0.9% Sodium Chloride Injection by HPLC伊立替康浓度测定及其输液稳定性考察
6.Clinical Study of Advanced Ovarial Cancer with Irinotecan and Cisplatin Regimen Combination伊立替康联合顺铂治疗晚期卵巢癌的疗效观察
7.The Efficacy Observation of Irinotecan Therapy of Patients with Recurrent Advanced Ovarian Carcinoma伊立替康治疗复发性晚期卵巢癌的临床观察
8.CLINICAL OBSERVATION ON THE IRINOTECAN PLUS CISPLATIN FOR ADVANCED ESOPHAGEAL CANCER伊立替康联合顺铂治疗晚期食管癌疗效观察
9.Irinotecan combined with capecitabine in line-2 treatment of locally advanced or metastatic gastric cancer伊立替康联合卡培他滨二线治疗晚期胃癌
10.Clinical Study of Combination Chemotherapy Based on CPT-11 on Hepatocellular Carcinoma;伊立替康联合化疗方案治疗原发性肝癌的临床研究
11.Clinical Study of Weekly Dose of Irinotecan Combined with Low Dose of FP Regiment in the Treatment of Patients with Metastatic Colorectal Cancer;周剂量伊立替康联合LD-FP持续灌注治疗晚期大肠癌的临床研究
12.Pharmacokinetic Study of Irinotecan by Co-administered Thalidomide;合用沙利度胺对盐酸伊立替康药代动力学影响的研究
13.Observing the Effect of Irinotecan Combined with Capecitabine Regimen on Patients with Metastatic Colon Carcinoma伊立替康联合卡培他滨治疗转移性结肠癌临床观察
14.Treatment of extensive-stage small cell lung cancer with irinotecan plus cisplatin伊立替康联合顺铂治疗广泛期小细胞肺癌的临床观察
15.Preparation and quality evaluation of irinotecan hydrochloride lyophilized liposomes盐酸伊立替康脂质体冻干粉针的制备及其质量评价
16.The combination of capecitabine and irinotecan in treating 38 cases of advanced colorectal cancer as second-line chemtherapy regimen伊立替康联合卡培他滨二线治疗38例晚期结直肠癌的临床观察
17.A study on the relationship between the adverse events of irinotecan-based chemotherapy and UGT1A1*28 gene polymorphism伊立替康化学治疗的不良反应与UGT1A1*28基因多态性的关系
18.Bacillus licheniformis granules combined with Gentamycin for prevention of irinotecan-induced diarrhea地衣芽胞杆菌活菌制剂联合庆大霉素预防伊立替康所致腹泻
相关短句/例句
Irinotecan伊立替康
1.Advancement in the Synthesis and Clinical Application of the New Anticancer Drug Irinotecan;抗肿瘤新药伊立替康的合成和应用进展
2.The adverse reactions and management of irinotecan;盐酸伊立替康的不良反应及其预防处理
3.Short-term effects of irinotecan plus capecitabine as first-line treatment for advanced colorectal carcinoma;伊立替康联合卡培他滨—线治疗晚期结直肠癌的近期疗效
3)Irinotecan hydrochloride盐酸伊立替康
1.Preparation and quality evaluation of irinotecan hydrochloride lyophilized liposomes盐酸伊立替康脂质体冻干粉针的制备及其质量评价
2.Preparation of irinotecan hydrochloride containing liposomes by ammonium sulfate gradient method and its release in vitro硫酸铵梯度法制备盐酸伊立替康脂质体及体外释放的研究
3.METHODS:Irinotecan hydrochloride liposome was prepared by ammonium sulfate gradient method.目的:制备盐酸伊立替康脂质体并考察其体外释药特性。
4)irinotecan/therapeutic use伊立替康/治疗应用
5)Irinotecan hydrochloride trihydrate盐酸伊立替康三水合物
6)Irinotecan伊利替康
1.Irinotecan versus Oxaplatin in Combination with 5-FU/LV for Advanced Colorectal Cancer:A Systematic Review;奥沙利铂联合5-FU/LV与伊利替康联合5-FU/LV比较治疗晚期结直肠癌的系统评价
延伸阅读
伊立替康分子式:C33H38N4O6分子量:586.69CAS号:97682-44-5性质:暂无制备方法:暂无用途:抗癌药。
